| Filed On | Filing |
|---|---|
| 05 Jun 2009 |
Form 4/A: Syron Richard F/CA, Director
Received 2,500 shares by exercise or conversion · Exercised 2,500 Restricted Stock Units |
| 05 Jun 2009 |
Form 4/A: Mcgillicudy Cornelius Iii, Director
Received 2,500 shares by exercise or conversion · Exercised 2,500 Restricted Stock Units |
| 05 Jun 2009 |
Form 4/A: Dzau Victor J, Director
Received 2,500 shares by exercise or conversion · Exercised 2,500 Restricted Stock Units |
| 05 Jun 2009 |
Form 4/A: Cooney Charles L, Director
Exercised 2,500 Restricted Stock Units |
| 05 Jun 2009 |
Form 4/A: Carpenter Robert J, Director
Received 2,500 shares by exercise or conversion · Exercised 2,500 Restricted Stock Units |
| 05 Jun 2009 |
Form 4/A: Boudreaux Gail, Director
Received 2,500 shares by exercise or conversion · Exercised 2,500 Restricted Stock Units |
| 05 Jun 2009 |
Form 4/A: Berthiaume Douglas A, Director
Received 2,500 shares by exercise or conversion · Exercised 2,500 Restricted Stock Units |
| 03 Jun 2009 |
Form 4/A: Cooney Charles L, Director
Received 2,500 shares by exercise or conversion |
| 04 Aug 2008 |
Form 4/A: Smith Alan E, Senior Vice President
Received 18,455 shares as a grant or award · Sold 18,455 shares ($1.47M) · Exercised 18,455 Genzyme NQ stock option (right to buy) ($489K) |
| 04 Aug 2008 |
Form 4/A: Bamforth Mark R, Sr.VP, Corp. Operations & Phar
Acquired 6,445 Genzyme NQ stock option (right to buy) (Other Transaction) ($210K) |
| 02 Aug 2007 |
Form 4/A: Genzyme Corp, 10% owner and 1 other · BIOENVISION INC
Bought 8,398,098 shares ($47M) · Acquired 2,250,000 Series A Convertible Participating Preferred Stock (Open Market Purchase) ($25.3M) |
| 16 Jul 2007 |
Form 4/A: Genzyme Corp, 10% owner and 1 other · BIOENVISION INC
Bought 8,613,567 shares ($48.2M) · Acquired 2,250,000 Series A Convertible Participating Preferred Stock (Open Market Purchase) ($25.3M) |
| 16 Jun 2006 |
Form 4/A: Gemayel Georges, Executive Vice President
Bought 3,000 shares ($169K) |
| 21 Apr 2006 |
Form 4/A: Syron Richard F/CA, Director
Granted 15,000 Genzyme DOP stock option (right to buy) |
| 19 Jan 2006 |
Form 4/A: Moscicki Richard A, Senior Vice President
Received 21,344 shares by exercise or conversion ($323K) |
| 28 Dec 2005 |
Form 4/A: Moscicki Richard A, Senior Vice President
Sold 4,666 shares ($336K) |
| 01 Nov 2005 |
Form 4/A: Termeer Henri A, Director
Received 407,468 shares by exercise or conversion ($5.97M) · Sold 407,468 shares ($29.2M) |
| 25 May 2005 |
Form 4/A: Collier Earl M Jr, Executive Vice President
Received 70,000 shares by exercise or conversion ($2.28M) · Sold 70,000 shares ($4.5M) |
| 23 Aug 2004 |
Form 4/A: Smith Alan E, Senior Vice President
Received 35,196 shares by exercise or conversion ($497K) · Sold 35,196 shares ($1.81M) |
| 10 Feb 2004 |
Form 4/A: Collier Earl M Jr, Executive Vice President
Acquired 1,033 shares (Other Transaction) · Disposed of 19,870 shares (Other Transaction) · Disposed of 1,083 shares (Other Transaction) · 5 more |
Loading...